Abstract
PCV91 CAN Disparities between Health Technology Appraisal (HTA) Decisions Result in Inequitable Access to Treatment? the Case of NOVEL ORAL Anticoagulants (NOACS) in the Prevention of Stroke in NON-Valvular Atrial Fibrillation (NVAF)
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Paper version not known
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
